Biblio

7 resultats trouvés
Filtres: Auteur is Villet, R.  [Clear All Filters]
A
Berthelot A., De Nonneville A., Classe J.-M, Cohen M., Reyal F., Mazouni C., Chauvet M.P, Martinez A., Chopin N., Darai E. et al..  2019.  Adjuvant chemotherapy in elderly breast cancer patients: Pattern of use and impact on overall survival. ANNALS OF ONCOLOGY. 30
Houvenaeghel G., Sabatier R., Reyal F., Classe J.M, Giard S., Charitansky H., Rouzier R., Faure C., Garbay J.R, Darai E. et al..  2016.  Axillary lymph node micrometastases decrease triple-negative early breast cancer survival. BRITISH JOURNAL OF CANCER. 115:1024-1031.
B
De Nonneville A., Goncalves A., Boher J-M., Classe J-M., Cohen M., Colombo P-E., Reyal F., Chauvet M-P., Jouve E., Darai E. et al..  2018.  Benefit of adjuvant systemic therapies in HR1 HER2-pT1ab node-negative breast carcinomas. ANNALS OF ONCOLOGY. 29
De Nonneville A., Goncalves A., Boher J-M., Classe J-M., Cohen M., Colombo P-E., Reyal F., Chauvet M-P., Jouve E., Darai E. et al..  2018.  Benefit of adjuvant systemic therapies in HR1 HER2-pT1ab node-negative breast carcinomas. ANNALS OF ONCOLOGY. 29
C
Houvenaeghel G., Goncalves A., Classe J.M, Garbay J.R, Giard S., Charytensky H., Cohen M., Belichard C., Faure C., Uzan S. et al..  2014.  Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study. ANNALS OF ONCOLOGY. 25:623-628.
I
Houvenaeghel G., Boher J.M, Reyal F., Cohen M., Garbay J.R, Classe J.M, Rouzier R., Giard S., Faure C., Charitansky H. et al..  2016.  Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes. EUROPEAN JOURNAL OF CANCER. 67:106-118.
L
Jauffret C., Houvenaeghel G., Classe J.-M, Garbay J.-R, Giard S., Charitansky H., Cohen M., Belichard C., Faure C., Darai E. et al..  2015.  Lobular invasive breast cancer prognostic factors: About 940 patients. GYNECOLOGIE OBSTETRIQUE & FERTILITE. 43:712-717.